Abstract
Introduction: In the present study, our aim was to identify differentially expressed genes involved in estrogen actions at the endometrium level in rats. Methods: Thirty adult rats were ovariectomized four days prior to drug administration for 48 days. Rats were divided in 2 groups: I, control and II, conjugated equine estrogens (CCE). Total RNA was isolated from uterus, and differential expression was analyzed by array technology and RT-PCR. Results: A total of 32 candidate genes were shown to be upregulated or downregulated in groups I or II. Among them, differential expression was already confirmed by RT-PCR for IGFBP5, S12, c-kit, and VEGF, genes whose expression was up regulated during CCE therapy, and casein kinase II and serine kinase expression was the same level in both groups. Conclusion: We have demonstrated that cDNA array represents a powerful approach to identify key molecules in the estrogens therapy. A number of the candidates reported here should provide new markers that may contribute to the detection of target estrogen receptor. This information may also aid the development of new approaches to therapeutic intervention.
Key words
Uterus - Array - Estrogen - Rat - Pharmacogenomic
References
-
1
Evans W E, Relling M V.
Pharmacogenomics: translating functional genomics into rational therapeutics.
Science.
1999;
286
487-491
-
2
Debouck C, Goodfellow P.
DNA microarrays in drug discovery and development.
Nature Genet.
1999;
21
48-50
-
3
Afshari C A, Nuwaysir E F, Barrett J C.
Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation.
Cancer Res.
1999;
59
4759-4760
-
4
Wang A, Pierce A, Kremer K J, Gaddis S, Aldaz C M, Johnson D G. et al .
Rapid analysis of genes expression (RAGE) facilitates universal expression profiling.
Nucleids Acids Res.
1999;
27
4609-4618
-
5
Lander E S.
Array of hope.
Science.
1996;
274
536-539
-
6
Chen J JW, Wu R, Yang P-C, Huang J-Y, Sher Y-P, Han M-H. et al .
Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection.
Genomics.
1998;
51
313-324
-
7
Duggan D J, Bittner M, Chen Y, Meltzer P, Trent J.
Expression profiling using cDNA microarrays.
Nature Genet.
1999;
21
10-14
-
8
Brown P O, Botstein D.
Exploring the new world of the genome with DNA microarray.
Nature Genet.
1999;
21
33-37
-
9
Merki-Feld G S, Imthurn B, Keller P J.
The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels.
Horm Metab Res.
2000;
32
288-293
-
10
Andrade P M, Baracat E C, Simões M J, Lima G R.
Histomorphometric aspects of adult castrated rat endometrium after the use of estrogen, progesterone and tamoxifen.
Clin Exp Obst & Gyn.
2000;
27
138-141
-
11
He G, Pedersen S B, Bruun J M, Richelsen B.
Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen.
Horm Metab Res.
2000;
32
515-520
-
12
Pestell R G, Albanese C, Reutens A T, Segall J E, Lee R J, Arnold A.
The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation.
Endocrine Rev.
1999;
20
501-534
-
13
Samsioe G.
Hormone replacement therapy: aspects of bleeding problems and compliance.
Int J Menopausal Stud.
1996;
41
11-15
-
14
Mizuno K, Tanaka T, Umesaki N, Ogita S.
Inhibition of cAMP-mediated decidualization in human endometrial stromal cells by IL-1β and laminin.
Horm Metab Res.
1999;
31
307-310
-
15 Leatke R, Burghhardt E. Endometrial cancer steroid receptor. In: Surgical Gynecologic Oncology, Thieme Medical Publ New York; 1993: 366
-
16
Mallmann E S, Ribeiro MF M, Spritzer P M.
Effect of serotonin depletion by p-chlorophenylalanine on serum prolactin levels in estrogen-treated ovariectomized rats: insights concerning the serotoninergic, dopaminergic and opiois systems.
Horm Metab Res.
2001;
33
337-342
-
17
Claverie J-M.
Computational methods for the identification of differential and coordinated gene expression.
Hum Mol Genetics.
1999;
8
1821-1832
-
18
Debouck C, Goodfellow P N.
DNA microarrays in drug discovery and development.
Nat Genet.
1999;
21
48-50
-
19
Zhou J, Dsupin B A, Giudice L C, Bondy C A.
Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.
J Clin Endocrinol Metab.
1994;
79
1723-1734
-
20
Figueroa J A, de Raad S, Tadlock L, Speights V O, Rinehart J J.
Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer.
J Urol.
1998;
159
1379-1383
-
21
Hyder S M, Nawaz Z, Chiappetta C, Stancel G M.
Endocrinology identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
Cancer Res.
2000;
60
3183-3190
-
22
Dvorak H F, Brown L F, Detmar M, Dvorak A M.
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Am J Pathol.
1995;
146
1029-1039
-
23
Hyder S M, Stancel G M.
Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins.
Mol Endocrinol.
1999;
13
806-811
-
24
O’Brien K A, Lemke S J, Cocke K S, Rao R N, Beckmann R P.
Casein kinase 2 binds to and phosphorylates BRCA1.
Biochem Biophys Res Commun.
1999;
260
658-664
-
25
Glaeser M, Floetotto T, Hanstein B, Beckmann M W, Niederacher D.
Gene amplification ans expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas.
Horm Metab Res.
2001;
33
121-126
-
26
Meisner H, Heller-Harrison R, Buxton J, Czech M P.
Molecular cloning of the human casein kinase II alpha subunit.
Biochemistry.
1989;
28
4072-4076
-
27
Dobrowolska D W, Krebs G, Litchfield E G.
Regulation of casein kinase II by growth factors: a reevaluation.
Cell Mol Biol Res.
1994;
40
373-381
-
28
Karlsson A, Helou K, Walentinsson A, Hedrich H J, Szpirer C, Levan G.
Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
Genes Chromosomes Cancer.
2001;
31
345-356
-
29
Kho C J, Zarbl H.
Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria.
Proc Natl Acad Sci USA.
1992;
89
2200-2204
P. M. Andrade
Federal University of São Paulo
·Av. Dr. Altino Arantes, 835, apt.41 ·
São Paulo, SP · 04042-034 · Brazil
Telefon: + 55 (11) 55612111
Fax: + 55 (11) 30859497 ·
eMail: priscila.toco@epm.br
